ANDREA ROTHMEIER

Vice President, Discovery Biology 1859, Inc.

Andrea Rothmeier, Vice President of Discovery Biology at 1859 Inc., built from scratch and leads the company’s cross-functional assay development team; implemented unique, powerful screening capabilities for drug targets; and served as a key spokesperson for investment rounds. She has built a cross-functional team of biologists, chemists and bioengineers who work collaboratively to enable new assay capabilities utilizing 1859’s proprietary technology. She has mentored junior employees, including facilitating the transition of female direct reports from the research bench to software development and business development roles. Previously at Organovo, Rothmeier led the team development to improve processes and functionality of 3-D bio-printed liver tissues for diagnostic/therapeutic discovery use. At Scripps Research, she discovered novel therapeutic targets and diagnostic biomarkers in cardiovascular disease and cancer. She has volunteered in several capacities for the San Diego Food Bank and Father Joe’s Villages. She can be reached at andrea@1859.ai.